Recent estimates from modelling studies have shown a decreasing trend in active HCV prevalence in the general population: 0.2% in 2019 [ 19 ] and 0.1% in 2022 [ 20 ] reflecting the large number of people treated with DAAs [ 21 ].
← all excerpts
Mortality Attributable to Hepatitis B and C in Italy, Romania, and Spain, 2022 Estimates.
1
—
—